COMMUNIQUÉS West-GlobeNewswire

Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering
08/03/2024
SAN FRANCISCO and WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company seeking to develop differentiated biologics for the treatment of [...]
President & CEO Letter to Shareholders
08/03/2024
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, March 07, 2024 (GLOBE NEWSWIRE) -- Dear Nova Leap Health Corp. (“Nova Leap” or the “Company”) Shareholders: [...]
Nova Leap Health Corp. Posts Record Fourth Quarter and 2023 Annual Financial Results
08/03/2024
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, March 07, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
PickleJar Debuts Nationwide Flyaway Contest With Garth Brooks
07/03/2024
In Partnership With Cumulus Media and Sponsored by Big Machine Records, Grand Prize Winners to see Garth Brooks Perform Live in Las Vegas HOUSTON, TX, March 07, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – PickleJar [...]
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
07/03/2024
FREMONT, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that it has opened a new 50,000-square-foot facility in Wuxi, China [...]
Ultimovacs ASA: Mandatory notification of trade by primary insiders
07/03/2024
Oslo, 7 March 2024: Langøya Invest AS, a closely related party of Ketil Fjerdingen, a board member and primary insider in Ultimovacs ASA, has today sold 596,006 shares in the company at an average price of NOK 9.5245 [...]
SkinCure Oncology Unveils New Skin Cancer Treatment Technology at American Academy of Dermatology Annual Meeting in San Diego March 8-12 Booth 3555
07/03/2024
BURR RIDGE, Ill., March 07, 2024 (GLOBE NEWSWIRE) -- SkinCure Oncology , the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for [...]
Alignment Healthcare to Participate in a Virtual Fireside hosted by Raymond James
07/03/2024
ORANGE, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that Thomas Freeman, chief financial officer, will participate in a virtual fireside conversation hosted by [...]
DBV Technologies Reports Full Year 2023 Financial Results and Business Update
07/03/2024
Montrouge, France, March 7, 2024 DBV Technologies Reports Full Year 2023 Financial Results and Business Update Advanced Viaskin™ Peanut clinical development programs in peanut-allergic toddlers (1 through 3 years old) [...]
DBV Technologies fait le point sur ses activités et publie ses résultats financiers de l’année 2023
07/03/2024
Montrouge, France, 7 mars 2024 DBV Technologies fait le point sur ses activités et publie ses résultats financiers de l’année 2023 Progression des programmes de développement clinique Viaskin™ Peanut chez les jeunes [...]
Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07/03/2024
NEW YORK and and WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH) (“Dianthus”), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody [...]
Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
07/03/2024
BOSTON, March 07, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced today that Lara [...]
The Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial Results
07/03/2024
- Grew 2023 Revenue 16%, System-wide Sales 12%, and System-wide Comp Sales 4% vs. 2022 - - Increased Clinic Count to 935 at Year-end 2023, Initiating Refranchising Program - SCOTTSDALE, Ariz., March 07, 2024 (GLOBE [...]
Scorpius Holdings, Inc. Announces Proposed Public Offering of Common Stock
07/03/2024
DURHAM, N.C., March 07, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX) (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization (CDMO), today announced [...]
Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
07/03/2024
Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology [...]
Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
07/03/2024
SOLANA BEACH, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases with an emphasis on Gimoti ® ( [...]
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
07/03/2024
MOUNTAIN VIEW, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced its financial [...]
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
07/03/2024
TORONTO, March 07, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free [...]
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
07/03/2024
BELGRADE, Mont., March 07, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today [...]

Pages